Updated Feb 14, 2020 03:56 PM ET
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The only way to fully access the Zacks Rank
F Value | F Growth | D Momentum | F VGM
Zacks Style Scores Education - Learn more about the Zacks Style Scores
The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.
An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.
The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.
Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The company's lead program is GDC-0084, a small molecule inhibitor of the PI3K / AKT / mTOR pathway, which is being developed to treat glioblastoma multiforme, the primary and most aggressive form of brain cancer. Kazia Therapeutics Limited, formerly known as Novogen Limited, is based in Sydney, Australia.
Three International Towers Level 24 300 Barangaroo Avenue
Sydney, C3 2000
|Industry||Medical - Biomedical and Genetics|
|Fiscal Year End||June|
|Last Reported Quarter||12/31/2019|
|Next EPS Date||NA|
|Current Quarter EPS Consensus Estimate||NA|
|Current Year EPS Consensus Estimate||-0.10|
|Estimated Long-Term EPS Growth Rate||NA|
|Next EPS Report Date||NA|
Price and Volume Information
|52 Week High||9.74|
|52 Week Low||2.24|
|20 Day Moving Average||9,622.00|
|Target Price Consensus||0.00|
|Trailing 12 Months||NA|
|vs. Previous Year||NA|
|vs. Previous Quarter||NA|
|vs. Previous Year||NA%|
|vs. Previous Quarter||NA%|
|Price / Sales||NA|